Voltar
Artigo Revisado por pares
BIBTEX RIS

Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer

2010; Springer Science+Business Media; Volume: 123; Issue: 2 Linguagem: Inglês

10.1007/s10549-010-1002-0

ISSN

1573-7217

Autores

Christopher Lobo, Gilberto Lopes, Odalys Baez, Aurelio Castrellon, Annapoorna Ferrell, Connie Higgins, Erin Hurley, Judith Hurley, Isildinha M. Reis, Stephen P. Richman, Pearl H. Seo, Orlando Silva, Joyce M. Slingerland, K. Tukia, Catherine F. Welsh, Stefan Glück,

Tópico(s)

Colorectal Cancer Treatments and Studies

Referência(s)